ConductScience.org, home

Gene · 950

NIH grants835

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleSCARB2 papersNewest fiscal year
ZIAAG000297Bioanalysis, Drug Metabolism and New Drug Discovery12025
ZIAAG000343Metabolomic signatures underlying cognitive and motor decline in the development of mild cognitive impairment and Alzheimer's disease12025
ZIAAG000386Age-associated alterations in pro-inflammatory gene expression in humans12025
ZIAAG000936Alzheimers Disease Project: Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging population12025
ZIAAG000948Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease12025
ZIAAG000975ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders12025
ZIAAG000995Changes in muscle biomechanical quality with aging: causes and consequences12025
ZIAAG000996GESTALT-Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing12025
ZIABC010309Nuclear Architecture and Disease12025
ZIADK043400Early Detection Of Renal Injury12025
ZIADK054503Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases12025
ZIAES103166DNA Microarray Data Analysis12025
ZIAHD000196Phosphoinositide-calcium Signaling In Cell Regulation12025
ZIAHD000910Childhood Neurodegenerative Lysosomal Storage Disorders12025
ZIAHD008967Genetic epidemiology of early growth and cardiometabolic diseases12025
ZIAHL000140Lysosomal Diseases12025
ZICES102445Gene Expression and Microarrays12025
ZICHL000338Biophysics Core Facility12025
ZICTR000041Functional Genomics Laboratory (FGL)12025
ZIGHL006020NHLBI Animal Program Division12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/950/grants?page=8